Clinical Trials Logo

Cancer Colorectal clinical trials

View clinical trials related to Cancer Colorectal.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05585866 Active, not recruiting - Acute Kidney Injury Clinical Trials

Propofol and Sevoflurane Anesthesia in Colorectal Cancer Surgery: Incidence of Acute Kidney Injury

PROSACC
Start date: November 22, 2021
Phase:
Study type: Observational

The goal of this observational study is to compare anesthetic modalities (intravenous propofol anesthesia with sevoflurane gas anesthesia) in patients who underwent colorectal cancer resection surgery regarding the outcome of acute kidney injury. The main questions it aims to answer are: - is there a difference in acute kidney injury incidence in the two anesthetic modalities? - is there a difference in plasma creatinine between the two anesthetic modalities? - are there any patient characteristics or intraoperative factors that effect the incidence of acute kidney injury in either anesthetic modality? The study will analyze data from the CAN clinical trial database. (Cancer and Anesthesia: Survival After Radical Surgery - a Comparison Between Propofol or Sevoflurane Anesthesia, NCT01975064)

NCT ID: NCT04726319 Active, not recruiting - Clinical trials for Coronary Artery Disease

Family History App in Personalized Medicine

FHAMe
Start date: September 20, 2021
Phase: N/A
Study type: Interventional

A complete family history (FH) may identify persons at high risk for certain conditions. They can be offered genetic testing and life-saving screening and treatment. In practice, complete FH is rarely collected or entered into the electronic medical record (EMR). The Family History Screening Questionnaire is a survey patients complete to tell whether they are at increased risk of specific cancers, heart disease or diabetes. We will test a new way to record FH that includes an app to improve use of FH by family physicians and patients. The strategy includes education for patients and physicians about the importance of FH; patient completion of the FH questionnaire prior to appointments; and prompts in the EMR. We expect this to help family physicians and patients interpret FH and make the best decisions. We will assess the proportion of patients with new EMR FH information. We will explore if the strategy increases appropriate referrals for screening and genetic consultation for those at increased FH risk. We will also obtain patients' and physicians' feedback on this strategy. This new approach may improve FH information exchange between patients and physicians, encourage shared decision-making and reduce cancer deaths and chronic disease burden.

NCT ID: NCT04392479 Active, not recruiting - Metastasis Clinical Trials

TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study.

TWICE-IRI
Start date: September 2, 2020
Phase: Phase 3
Study type: Interventional

Optimization of second-line therapy with aflibercept, irinotecan (day1 or day 1,3), 5fluorouracile and folinic acid in patients with metastatic colorectal cancer. A randomized Phase III study.

NCT ID: NCT03615599 Active, not recruiting - Cancer, Breast Clinical Trials

Plant-based Diets and Risk of Cancer in the Adventist Health Study-2

AHS-2
Start date: February 1, 2002
Phase:
Study type: Observational

The Adventist Health Study-2 is a long-term study, exploring the links between lifestyle, diet, and disease outcomes among Seventh-day Adventists. More than 96,000 church members from the U.S. and Canada are participating in the current study, AHS-2, conducted by researchers at the Loma Linda University School of Public Health.

NCT ID: NCT03036436 Active, not recruiting - Malignancy Clinical Trials

The IMPETUS Cancer Trial. A Technology Delivered Physical Activity Intervention in Cancer

IMPETUS
Start date: January 2017
Phase: N/A
Study type: Interventional

Participants will take part in a 12 week intervention, with at least one follow up at 24 +/- 2 weeks. Each participant will be provided with support, motivation and professional guidance about improving physical activity (PA) levels and will be given a commercially available PA tracker. The PA tracker will also include a smartphone or web-based application, where participants can upload their exercise performed each day, and keep up to date with their goals using their smartphone or by logging on to their computer. The aim of the study is to find out how useful and effective technology with support from a healthcare professional is in helping cancer survivors to become more physically active. This study will measure objective PA levels of the participants at the start of the study and at the end. The acceptability of using this intervention to promote PA in cancer survivors will also be investigated.

NCT ID: NCT02991677 Active, not recruiting - Cancer, Breast Clinical Trials

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Chemotherapy-induced peripheral neuropathy (CIPN) continues to be a serious healthcare concern. It is painful, persistent, resistant to conventional pain therapies, and results in long-term suffering and decreased quality of life for many cancer survivors. The role of exercise to decrease CIPN-related neuropathic pain (CIPN-NP) will be investigated, with the goal of identifying the mechanisms associated with this therapeutic approach to manage CIPN-NP.